Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

Zyrtec (cetirizine HCl)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved December 1995

Specific Treatments:

allergy

General Information

In Europe, Zyrtec is the most widely prescribed antihistamine. It is currently used in more than 90 countries. Zyrtec is characterized by a fast onset of action, which is important in relieving allergy symptoms that can include sneezing, runny nose and watery eyes. Zyrtec is well tolerated and has no known drug interactions.

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation